Complex Patient Care Topics in Hematologic Malignancies

Clinical trials of CAR T cell therapies have demonstrated that patients are most likely to develop signs and symptoms of cytokine release syndrome during which of the following timeframes?

For what duration of time do both patient and caregiver need to remain in close proximity to the cell therapy center following CAR T cell infusion?

A 69-year-old patient received a CAR T cell infusion 1 week ago. Significant decline in the patient's performance on serial handwriting evaluation would raise suspicion of which of the following adverse events associated with CAR T cell therapy?